{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:59:28Z","timestamp":1772575168964,"version":"3.50.1"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>This study aimed to investigate the sentinel lymph node (SLN) tumour burden to predict the non-SLN positivity rate and the survival of melanoma patients to evaluate whether SLN microstaging could predict the prognosis, similar to what is currently performed by examining the lymph nodes excised by complete lymph node dissection. Of 1130 consecutive melanoma patients who underwent SLN biopsy, 226 were tumour-positive and 204 were included in this study. SLN metastases were classified on the basis of dimensional (Rotterdam) and topographic (Dewar) criteria either separately or combined. SLN metastases more than 1\u2009mm in diameter had the highest non-SLN positivity rate (31%) compared with metastases 0.1\u20131\u2009mm (10%) and less than 0.1\u2009mm (4%). The non-SLN positivity rate was 45% for extensive metastases, 5% for subcapsular metastases and 23\u201329% for parenchymal, combined and multifocal classes, therefore suggesting a simplification of the parenchymal SLN metastases into only two classes: extensive and \u2018not extensive\u2019. The dimension of the metastasis was correlated with a different non-SLN positivity rate only when the metastasis was in the parenchyma (20\u201336%) and not when it was in the subcapsular location (4\u20137%). Interestingly, the 5-year melanoma-specific survival (MSS) was 89% for patients with subcapsular less than 0.1\u2009mm metastases and 45% for patients with nonsubcapsular more than 1\u2009mm metastases (<jats:italic toggle=\"yes\">P=<\/jats:italic>0.017). In the parenchyma, larger metastases (&gt;1\u2009mm) were related to a lower 5-year MSS (46%) than smaller (&lt;1\u2009mm) metastases (MSS 77%). SLN tumour burden characterization can be simplified and it can provide prognostic information on non-SLN positivity and survival, which is especially useful in patients who do not undergo complete lymph node dissection.<\/jats:p>","DOI":"10.1097\/cmr.0000000000000481","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T08:35:24Z","timestamp":1531989324000},"page":"163-171","source":"Crossref","is-referenced-by-count":14,"title":["Enhancing the prognostic role of melanoma sentinel lymph nodes through microscopic tumour burden characterization: clinical usefulness in patients who do not undergo complete lymph node dissection"],"prefix":"10.1097","volume":"29","author":[{"given":"Lorenzo","family":"Borgognoni","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Regional Melanoma Referral Center and Melanoma & Skin Cancer Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bellucci","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Regional Melanoma Referral Center and Melanoma & Skin Cancer Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Urso","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Dermatopathology Section, S.M. Annunziata Hospital, AUSL Toscana Centro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Manneschi","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Unit, Institute for Research, Prevention and Oncological Network (ISPRO), Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Gerlini","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Regional Melanoma Referral Center and Melanoma & Skin Cancer Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Brandani","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Regional Melanoma Referral Center and Melanoma & Skin Cancer Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Chiarugi","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Regional Melanoma Referral Center and Melanoma & Skin Cancer Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Gelli","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Regional Melanoma Referral Center and Melanoma & Skin Cancer Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanni","family":"Giannotti","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Regional Melanoma Referral Center and Melanoma & Skin Cancer Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Sestini","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Regional Melanoma Referral Center and Melanoma & Skin Cancer Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230902","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3322\/caac.20141","article-title":"Cancers with increasing incidence trends in the United States: 1999 through 2008","volume":"62","author":"Simard","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R2-20230902","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2011.40.3519","article-title":"Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline","volume":"30","author":"Wong","year":"2012","journal-title":"J Clin Oncol"},{"key":"R3-20230902","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"R5-20230902","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"R6-20230902","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008390-199508000-00008","article-title":"Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes","volume":"5","author":"Thompson","year":"1995","journal-title":"Melanoma Res"},{"key":"R7-20230902","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1245\/ASO.2004.01.026","article-title":"Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma","volume":"11","author":"Doubrovsky","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"R8-20230902","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2010.31.6760","article-title":"Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumour load and Dewar topography criteria","volume":"29","author":"Van der Ploeg","year":"2011","journal-title":"J Clin Oncol"},{"key":"R9-20230902","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"R10-20230902","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J Clin Oncol"},{"key":"R11-20230902","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1245\/ASO.2003.01.023","article-title":"Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years","volume":"10","author":"Estourgie","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"R12-20230902","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00008390-200302000-00007","article-title":"Sentinel lymph node biopsy in melanoma patients with clinical negative regional lymph nodes \u2013 one institution\u2019s experience","volume":"13","author":"Nowecki","year":"2003","journal-title":"Melanoma Res"},{"key":"R13-20230902","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.cmr.0000133968.28172.6e","article-title":"Sentinel node biopsy procedures with an analysis of recurrence patterns and prognosis in melanoma patients: technical advantages using computer assisted gamma probe with adjustable collimation","volume":"14","author":"Borgognoni","year":"2004","journal-title":"Melanoma Res"},{"key":"R15-20230902","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1245\/s10434-008-0187-5","article-title":"Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma","volume":"16","author":"Ariyan","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"R16-20230902","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1245\/s10434-008-9885-2","article-title":"Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R17-20230902","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"key":"R18-20230902","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1245\/ASO.2006.03.058","article-title":"Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study","volume":"13","author":"Wong","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R19-20230902","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1245\/s10434-014-3845-9","article-title":"International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin","volume":"21","author":"Melstrom","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R21-20230902","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamasurg.2013.3044","article-title":"Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system","volume":"148","author":"Leung","year":"2013","journal-title":"JAMA Surg"},{"key":"R22-20230902","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejso.2006.10.032","article-title":"Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma","volume":"33","author":"Van Akkooi","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"R23-20230902","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"R24-20230902","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/archsurg.139.4.400","article-title":"Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary?","volume":"139","author":"Elias","year":"2004","journal-title":"Arch Surg"},{"key":"R25-20230902","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1245\/s10434-010-1145-6","article-title":"Total sentinel lymph node tumour size predicts nonsentinel node metastasis and survival in patients with melanoma","volume":"17","author":"Cadili","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R26-20230902","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1200\/JCO.2006.06.3198","article-title":"Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival","volume":"24","author":"Cascinelli","year":"2006","journal-title":"J Clin Oncol"},{"key":"R27-20230902","first-page":"301","article-title":"Prognostic significance of microscopic tumour burden in sentinel lymph node in patients with cutaneous melanoma","volume":"35","author":"Kim","year":"2015","journal-title":"Anticancer Res"},{"key":"R28-20230902","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2004.01.012","article-title":"Factors predictive of tumour-positive nonsentinel lymph nodes after tumour-positive sentinel lymph node dissection for melanoma","volume":"22","author":"Lee","year":"2004","journal-title":"J Clin Oncol"},{"key":"R29-20230902","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jamcollsurg.2005.03.029","article-title":"Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma","volume":"201","author":"Sabel","year":"2005","journal-title":"J Am Coll Surg"},{"key":"R30-20230902","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jso.21465","article-title":"Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma","volume":"101","author":"Cadili","year":"2010","journal-title":"J Surg Oncol"},{"key":"R31-20230902","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ejso.2013.02.022","article-title":"Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis","volume":"39","author":"Nagaraja","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"R32-20230902","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2013.08.023","article-title":"The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients","volume":"50","author":"Van der Ploeg","year":"2014","journal-title":"Eur J Cancer"},{"key":"R33-20230902","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.amjsurg.2015.05.016","article-title":"Predictive factors for sentinel lymph nodes and non-sentinel lymph nodes metastatic involvement: a database study of 1,041 melanoma patients","volume":"211","author":"Kibrit\u00e9","year":"2016","journal-title":"Am J Surg"},{"key":"R34-20230902","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12957-015-0701-8","article-title":"The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique","volume":"13","author":"Rutkowski","year":"2015","journal-title":"World J Surg Oncol"},{"key":"R35-20230902","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1200\/JCO.2007.15.4179","article-title":"Microscopic tumour burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma","volume":"26","author":"Gershenwald","year":"2008","journal-title":"J Clin Oncol"},{"key":"R36-20230902","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/annonc\/mdl176","article-title":"Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?","volume":"17","author":"Van Akkooi","year":"2006","journal-title":"Ann Oncol"},{"key":"R37-20230902","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1245\/s10434-015-4615-z","article-title":"Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases","volume":"22","author":"Holtkamp","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R38-20230902","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1200\/JCO.2010.30.9567","article-title":"Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes","volume":"28","author":"Murali","year":"2010","journal-title":"J Clin Oncol"},{"key":"R39-20230902","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1245\/s10434-007-9734-8","article-title":"Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node","volume":"15","author":"Rossi","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R40-20230902","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0194599815605494","article-title":"Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck","volume":"154","author":"Fritsch","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R41-20230902","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jso.21066","article-title":"Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients","volume":"98","author":"Glumac","year":"2008","journal-title":"J Surg Oncol"},{"key":"R42-20230902","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejso.2012.10.014","article-title":"Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients","volume":"39","author":"Wevers","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"R43-20230902","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.ejca.2009.08.015","article-title":"Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden","volume":"45","author":"Van Akkooi","year":"2009","journal-title":"Eur J Cancer"},{"key":"R44-20230902","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cll.2017.05.002","article-title":"Sentinel lymph nodes in cutaneous melanoma","volume":"37","author":"Prieto","year":"2017","journal-title":"Clin Lab Med"},{"key":"R45-20230902","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/bjs.5814","article-title":"Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma","volume":"94","author":"Van Akkooi","year":"2007","journal-title":"Br J Surg"},{"key":"R46-20230902","first-page":"87A","article-title":"Histologic quantification of tumor size in sentinel lymph node metastases correlates with prognosis in patients with cutaneous malignant melanoma","volume":"19","author":"Prieto","year":"2006","journal-title":"Mod Pathol"},{"key":"R47-20230902","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2133.2007.07937.x","article-title":"Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection","volume":"157","author":"Debarbieux","year":"2007","journal-title":"Br J Dermatol"},{"key":"R48-20230902","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1245\/s10434-016-5575-7","article-title":"Sentinel lymph node genes to predict prognosis in node-positive melanoma patients","volume":"24","author":"Hao","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R49-20230902","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.2004.12.177","article-title":"The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement","volume":"22","author":"Dewar","year":"2004","journal-title":"J Clin Oncol"},{"key":"R50-20230902","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1245\/s10434-017-6143-5","article-title":"Prediction of non-sentinel node status in patients with melanoma and positive sentinel node biopsy: An Italian Melanoma Intergroup (IMI) Study","volume":"25","author":"Rossi","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R51-20230902","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/1097-0142(20010601)91:11<2110::AID-CNCR1239>3.0.CO;2-Q","article-title":"A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma","volume":"91","author":"Starz","year":"2001","journal-title":"Cancer"},{"key":"R52-20230902","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/DAD.0000000000000488","article-title":"Increased angiogenesis and lymphangiogenesis in metastatic sentinel lymph nodes is associated with nonsentinel lymph node involvement and distant metastasis in patients with melanoma","volume":"38","author":"Pastushenko","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"R53-20230902","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00432-016-2323-0","article-title":"Prognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up","volume":"143","author":"Eigentler","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"R54-20230902","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jamcollsurg.2013.12.014","article-title":"Comparison of sentinel lymph node micrometastatic tumor burden measurements in melanoma","volume":"218","author":"Egger","year":"2014","journal-title":"J Am Coll Surg"},{"key":"R55-20230902","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/modpathol.3800117","article-title":"Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node","volume":"17","author":"Cochran","year":"2004","journal-title":"Mod Pathol"},{"key":"R56-20230902","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1245\/s10434-007-9472-y","article-title":"Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma","volume":"14","author":"Scheri","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R57-20230902","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/CMR.0000000000000202","article-title":"Metastatic area ratio can help predict nonsentinel node positivity in melanoma patients","volume":"26","author":"Bertolli","year":"2016","journal-title":"Melanoma Res"},{"key":"R58-20230902","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","article-title":"Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update","volume":"36","author":"Wong","year":"2018","journal-title":"J Clin Oncol"},{"key":"R59-20230902","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1056\/NEJMe1704290","article-title":"The enigma of regional lymph nodes in melanoma","volume":"376","author":"Coit","year":"2017","journal-title":"N Engl J Med"},{"key":"R60-20230902","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2017.09.002","article-title":"Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria","volume":"87","author":"Madu","year":"2017","journal-title":"Eur J Cancer"},{"key":"R61-20230902","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ctrv.2017.01.006","article-title":"Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: a network meta-analysis","volume":"54","author":"Pasquali","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"R62-20230902","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1470-2045(17)30015-3","article-title":"Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial","volume":"18","author":"Coens","year":"2017","journal-title":"Lancet Oncol"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008390-201904000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T04:00:38Z","timestamp":1693627238000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201904000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000481","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}